Search for: "Schering Corp"
Results 201 - 220
of 251
Sort by Relevance
|
Sort by Date
1 Nov 2008, 5:29 am
Jurors found that Warrick Pharmaceutical, Schering Corp. and Schering-Plough Corp. encouraged pharmacies and other healthcare providers to purchase drugs above the average wholesale price. [read post]
24 Oct 2008, 7:49 pm
In one of those cases, Schering-Plough Corp. v. [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
2 Sep 2008, 11:57 am
``This can't help'' the drug's sales, Gordon Tomaselli, a spokesman for the American Heart Association and a cardiologist at Johns Hopkins University School of Medicine in Baltimore, said in an interview at the European Society of Cardiology conference in Munich today.Source.By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [read post]
21 Aug 2008, 6:02 pm
A congressional committee is demanding that the makers of controversial cholesterol drug Vytorin, Merck & Co. and Schering-Plough Corp., produce extensive data related to a clinical study indicating the drug might increase the risk of cancer.Rep. [read post]
21 Jul 2008, 3:49 pm
Stock down 10%, then recoups all the losses by midday, then down 15% as Vytorin, an anti-cholesterol agent jointly sold by Merck & Co. and Schering-Plough Corp., failed to show it was effective in stopping progression of a cardiac condition known as aortic stenosis, a partial blockage of the heart's aortic valve, Norwegian researchers said Monday.Whew . . . what a roller coaster . . .But there's more:There were numerically more cancer deaths in the group of… [read post]
3 Jul 2008, 7:26 pm
Baxter Healthcare Corp., 794 F. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
17 Apr 2008, 10:39 am
Novartis Pharmaceuticals Corp., ___ F. [read post]
1 Apr 2008, 11:03 pm
This week, there was a release of new evidence supporting the suspicions.The Senate's committee has said that the researcher who led a crucial study of the drug accused Vytorin makers Merck & Co. and partner Schering-Plough Corp. actually withheld. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
22 Feb 2008, 1:30 pm
In a crushing blow to consumers, on Thursday, February 21st, the United States Supreme Court again sided with big pharmaceutical medical device makers. [read post]
19 Feb 2008, 7:09 pm
The largest single recovery was a $900 million settlement Tenet Healthcare Corp. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
15 Feb 2008, 1:49 am
The FDA has approved a change in the product labels for cholesterol drugs Vytorin and Zetia, adding depression as a possible side effect of the drug.In letters to the drugs' co-marketers, Schering-Plough Corp. [read post]
4 Feb 2008, 8:23 am
Schering-Plough Corp., No. 06-06823, 2007 WL 1839789 (N.D. [read post]
25 Jan 2008, 12:12 pm
Here's an excerpt: Merck & Co. and Schering-Plough Corp. defended their actions Friday involving a recently released study that raised questions about... [read post]
21 Jan 2008, 9:41 pm
Inc. and Schering-Plough Corp. [read post]
